Table 1.
Inclusion criteria
| Randomised controlled trials (RCTs) and observational studies using rifaximin to eradicate SIBO |
| Patients aged ≥18 years |
| Test to diagnose SIBO reported |
| Criteria to consider a test positive for SIBO reported |
| Follow‐up performed to assess eradication |
| Rifaximin regimens reporteda |
| Studies not including patients with neoplastic diseases |
a
Studies using cyclic treatment of rifaximin or reporting more than one dosage of rifaximin tested but not indicating the number of patients treated with each dosage were not included.